Impact of nonsynonymous mutations of factor X on the functions of factor X and anticoagulant activity of edoxaban
Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus
Association of selenoprotein S gene polymorphism with ischemic stroke in a Chinese case–control study
Results of rotational thromboelastometry, coagulation activation markers and thrombin generation assays in orthopedic patients during thromboprophylaxis with rivaroxaban and enoxaparin
How do we encounter rare factor deficiencies in children? Single-centre results from Turkey
Chemical sympathectomy attenuates inflammation, glycocalyx shedding and coagulation disorders in rats with acute traumatic coagulopathy
Carrier and prenatal diagnostic strategy and newly identified mutations in Hungarian haemophilia A and B families
Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients
Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia
Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease
Momordica charantia seed extract exhibits strong anticoagulant effect by specifically interfering in intrinsic pathway of blood coagulation and dissolves fibrin clot
Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity
Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia
Acquired hemophilia A in the HIV-infected patient
Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia
Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association?
Treatment of mechanical valve thrombosis in the right heart
A novel nonsense mutation Tyr301* of PROS1 causing protein S deficiency
Dabigatran overdose
Confounding factors should be considered in the evaluation of mean platelet volume in nonvalvular atrial fibrillation
Dysfibrinogenaemia associated with a novel heterozygous mutation in FGB (c.680delG) and a mild clinical history of bleeding
Coagulation profile, H1N1 influenza A infection and hematological malignancies
High iron content of Ankaferd hemostat as a clue for its hemostatic action of red blood cell origin
Thrombelastography will not predict bleeding if normal
Evaluation of mean platelet volume with four hematological analyzers